KarenLTedescoMD

PubMed

• 12 citations
  Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
  , , , , , , , , , , , , , , , , , > ;NPJ Breast Cancer. 2021 Jun 11
• 4 citations
  Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.
  Amy Irwin, Lori Jensen, Karen L. Tedesco, Soamnauth Misir, Wei Zhu, Ana Almonte, Yaohua He, Ran Xie, Martin Olivo, Joyce O'Shaughnessy> ;Clinical Breast Cancer. 2020 Apr 1
• 9 citations
  An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.
  Jeffrey L. Vacirca, Arlene Chan, Klára Mezei, Clarence S. Adoo, Zsuzsanna Pápai, Kimberly McGregor, Meena Okera, Zsolt Horváth, László Landherr, Jerzy Hanslik, Steven ...> ;Cancer Medicine. 2018 May 1
• 1 citations
  Primary Neuroendocrine Carcinoma of the Middle Mediastinum Involving the Right Main Pulmonary Artery
  Charles T. Bakhos, Stephani C. Wang, Karen L. Tedesco, Arsyl D. DeJesus, Sahar Nozad, Harry J. Depan> ;The Annals of Thoracic Surgery. 2016 Apr 1
• Final results of a phase II trial of trabectedin (T) in triple-negative, HER2-positive, and BRCA1/2 germ-line-mutated metastatic breast cancer (MBC) patients (pts).
  Tedesco KL, Blum JL, Goncalves A, Lubinski J, Osborne CRC, Lardelli P, Tercero JC, Florez A, Holmes FA, Delaloge S> ;J. Clin. Oncol.. 2011-05-20
• 13 citations
  Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
  Kristi McIntyre, Patrick V. Acevedo, Carlos A. Encarnacion, Karen L. Tedesco, Yunfei Wang, Lina Asmar, Joyce A. O'Shaughnessy> ;Breast Cancer Research and Treatment. 2009 May 21
• Preliminary safety and activity results of trabectedin in a phase II trial dedicated to triple-negative (ER-, PR-, HER2-), HER2+++, or BRCA1/2 germ-line-mutated metast...
  Delaloge S, Tedesco KL, Blum J, Gonçalves A, Lubinski J, Efrat N, Osborne C, Lebedinsky C, Tercero JC, Holmes FA> ;J. Clin. Oncol.. 2009-05-20
• 6 citations
  A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas
  Karen L. Tedesco, Jordan Berlin, Mace L. Rothenberg, Hak Choy, Ken Wyman, Adrian Scott Pearson, Robert D. Beauchamp, Nipun B. Merchant, A. Craig Lockhart, Yu Shyr, Car...> ;Radiotherapy and Oncology. 2005 Jul 1
• 1 citations
  Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
  Karen L. Tedesco, Jordan Berlin, Charles D. Blanke, Ming Teng, Hak Choy, John Roberts, R. Daniel Beauchamp, Steve Leach, Ken Wyman, John L. Tarpley, Yu Shyr, Carol Cai...> ;International Journal of Radiation Oncology, Biology, Physics. 2005 Apr 1
• 12 citations
  The epidermal growth factor receptor as a target for gastrointestinal cancer therapy
  Karen L. Tedesco, A. Craig Lockhart, Jordan Berlin> ;Current Treatment Options in Oncology. 2004 Oct 1
• 81 citations
  Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-In...
  Karen L. Tedesco, Ann D. Thor, David H. Johnson, Yu Shyr, K. A. Blum, L. J. Goldstein, W. J. Gradishar, Brenda P. Nicholson, Douglas E. Merkel, D. Murrey, S. Edgerton,...> ;Journal of Clinical Oncology. 2004 Mar 15
• 14 citations
  Prostate cancer early detection practices among men with a family history of disease.
  Cathryn H. Bock, Patricia A. Peyser, Stephen B. Gruber, Susan E. Bonnell, Karen L. Tedesco, Kathleen A. Cooney> ;Urology. 2003 Sep 1
• Join now to see all